Keywords: SkyePharma, Abbott Labs, Flutiform, NDA, FDA, Licensing

SkyePharma takes back NDA for Flutiform from Abbott Labs

Article | 08 February 2010

Print This

The UK’s drug formulation specialist SkyePharma says that the US New Drug Application for its investigation asthma drug Flutiform ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in